DONATE TODAY
To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

August 1, 2022

CALL TO ACTION:
INCREASE CAPACITY & SUSTAINABILITY

To create increased impact in the health and research industries and to help www.EndBrainCancer.org reach its goal of moving forward from an annual $350,000 501 (c)3 non-profit organization to a $2M 501 (c)3 non-profit social enterprise organization, the End Brain Cancer Initiative’s (EBCI’s) Board of Directors is growing and is currently seeking the following positions and skills to join our U.S. Board:

  1. Attorney specializing in 501 (c)3 non-profit governance
  2. Attorney specializing in Service Contracts and Contract Negotiations
  3. Philanthropist – make introductions to large donors within their network who desire to financially support EBCI’s Mission at $50,000 annually
  4. Development Director – develop/implement/execute/manage a Development/Individual Donor Program with goal of bringing into EBCI to support mission & capacity $250,000 annually in new revenue
  5. TV Media Specialist – advance mission/disease education via utilizing own network for media appearances/speaking engagements, etc.
  6. Health Insurance Benefits VP for a large U.S. Health Insurance company and/or large U.S. Employer

If you are the right fit, please send Cover Letter and Resume directly to Dellann@EndBrainCancer.org. The End Brain Cancer Initiative and I thank you in advance for your desire to serve in order to grow patient access and EBCI’s capacity, sustainability and IMPACT.

Photo of Dellann

Dellann Elliott Mydland
President & Board Chair

The EndBrainCancer Initiative | Chris Elliott Fund
Dellann@EndBrainCancer.org

EndBrainCancer.org

ENDBRAINCANCER INITIATIVE | CHRIS ELLIOTT FUND

Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
DONATE
corporate partners
upcoming events
resources
About us
envelopephonemap-markerpointer-right
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram